KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Long-Term Investments (2017 - 2022)

Historic Long-Term Investments for Guardant Health (GH) over the last 6 years, with Q3 2022 value amounting to $156.7 million.

  • Guardant Health's Long-Term Investments fell 3736.02% to $156.7 million in Q3 2022 from the same period last year, while for Sep 2022 it was $156.7 million, marking a year-over-year decrease of 3736.02%. This contributed to the annual value of $698.0 million for FY2021, which is 18306.67% up from last year.
  • Latest data reveals that Guardant Health reported Long-Term Investments of $156.7 million as of Q3 2022, which was down 3736.02% from $382.6 million recorded in Q2 2022.
  • Over the past 5 years, Guardant Health's Long-Term Investments peaked at $698.0 million during Q4 2021, and registered a low of $3.0 million during Q3 2018.
  • Its 5-year average for Long-Term Investments is $235.6 million, with a median of $242.4 million in 2020.
  • Its Long-Term Investments has fluctuated over the past 5 years, first skyrocketed by 1011343.23% in 2019, then plummeted by 8301.59% in 2020.
  • Quarter analysis of 5 years shows Guardant Health's Long-Term Investments stood at $77.6 million in 2018, then soared by 246.54% to $268.8 million in 2019, then dropped by 8.25% to $246.6 million in 2020, then soared by 183.07% to $698.0 million in 2021, then tumbled by 77.55% to $156.7 million in 2022.
  • Its Long-Term Investments stands at $156.7 million for Q3 2022, versus $382.6 million for Q2 2022 and $588.5 million for Q1 2022.